- Report
- October 2026
- 473 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 172 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 270 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 470 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 388 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 377 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 268 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 287 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 590 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 181 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 287 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 476 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 379 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 278 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 381 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 276 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 285 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 282 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 204 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more